Texas Permanent School Fund raised its position in Heska Corp (NASDAQ:HSKA) by 5.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,470 shares of the medical research company’s stock after purchasing an additional 224 shares during the period. Texas Permanent School Fund owned 0.06% of Heska worth $385,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. We Are One Seven LLC bought a new stake in shares of Heska in the 4th quarter valued at $86,000. LS Investment Advisors LLC increased its stake in shares of Heska by 30.1% in the 4th quarter. LS Investment Advisors LLC now owns 1,133 shares of the medical research company’s stock valued at $98,000 after acquiring an additional 262 shares in the last quarter. Bank of Montreal Can increased its stake in shares of Heska by 11.7% in the 4th quarter. Bank of Montreal Can now owns 1,876 shares of the medical research company’s stock valued at $162,000 after acquiring an additional 196 shares in the last quarter. Greenwood Capital Associates LLC bought a new stake in shares of Heska in the 3rd quarter valued at $210,000. Finally, Virtu Financial LLC bought a new stake in shares of Heska in the 3rd quarter valued at $223,000. Hedge funds and other institutional investors own 84.72% of the company’s stock.
In other Heska news, COO Jason A. Napolitano sold 7,500 shares of the business’s stock in a transaction on Friday, January 25th. The shares were sold at an average price of $95.58, for a total transaction of $716,850.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold a total of 27,329 shares of company stock valued at $2,638,829 in the last 90 days. 14.00% of the stock is currently owned by company insiders.
Heska (NASDAQ:HSKA) last announced its quarterly earnings results on Tuesday, February 26th. The medical research company reported $0.46 EPS for the quarter, missing the Zacks’ consensus estimate of $0.75 by ($0.29). The business had revenue of $34.06 million for the quarter, compared to the consensus estimate of $40.59 million. Heska had a net margin of 4.59% and a return on equity of 9.87%.
Several analysts have recently weighed in on the stock. Sidoti lowered shares of Heska from a “buy” rating to a “neutral” rating in a research note on Tuesday, February 26th. BidaskClub upgraded shares of Heska from a “sell” rating to a “hold” rating in a research note on Wednesday, March 27th. Zacks Investment Research lowered shares of Heska from a “buy” rating to a “hold” rating in a research note on Friday, February 8th. B. Riley decreased their price target on shares of Heska from $93.00 to $87.00 and set a “neutral” rating for the company in a research note on Wednesday, February 27th. Finally, Benchmark lowered shares of Heska from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $109.00.
ILLEGAL ACTIVITY NOTICE: “Texas Permanent School Fund Acquires 224 Shares of Heska Corp (NASDAQ:HSKA)” was originally posted by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/04/15/texas-permanent-school-fund-buys-224-shares-of-heska-corp-hska.html.
Heska Company Profile
Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; COAG veterinary analyzers; Element i immunodiagnostic analyzers; and IV infusion pumps.
Further Reading: Strike Price
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.